Sudoscan to Exhibit at the
24th Francophone ENMG Congress in Antibes
Sudoscan is pleased to announce its participation in the 24th Journées Francophones de l’ElectroNeuroMyoGraphie (SF-ENMG), taking place from June 3 to 5, 2026 at the Antipolis Congress Center in Antibes Juan-les-Pins, France.
Recognized as a key event in the French-speaking neurophysiology community, the SF-ENMG congress brings together neurologists, neurophysiologists, clinicians, researchers, and healthcare professionals involved in electrodiagnostic medicine and neuromuscular disorders.
Sudoscan will be present to showcase its innovative, non-invasive technology dedicated to the assessment of small fiber and autonomic neuropathies.
About the SF-ENMG Congress 2026
The SF-ENMG congress is dedicated to clinical practice in electroneuromyography and aims to encourage scientific exchange between clinicians, neurophysiologists, researchers, and healthcare professionals across French-speaking countries.
The 2026 edition in Antibes will feature a programme combining practical workshops, scientific sessions, and expert discussions focused on everyday clinical applications in neurophysiology.
The congress will notably address:
● Clinical approaches to neuromuscular disorders
● Interactive workshops in electroneuromyography
● The growing role of artificial intelligence in neurophysiology
● Practical case discussions and experience sharing between experts
With its balance of education, scientific updates, and hands-on learning, the SF-ENMG congress offers a collaborative environment dedicated to advances in neurological and neurophysiological practice.
If you want to learn more about the programme of the 2026 SF-ENMG congress, click here.
Sudoscan: Supporting Neuropathy Assessment in Clinical Practice
Sudoscan is a CE-certified and FDA-cleared Class IIa medical device that enables a fast and non-invasive assessment of sudomotor function through the measurement of Electrochemical Skin Conductance (ESC).
By evaluating small nerve fiber function, Sudoscan helps clinicians identify autonomic and peripheral neuropathies at an early stage.
● Results in less than 3 minutes
● No patient preparation required
● Non-invasive and easy to use
● Supported by numerous peer-reviewed publications
Sudoscan is increasingly used in both clinical and research settings, particularly in neurology, diabetology, and neurophysiology.
For more studies on the efficacy of Sudoscan’s technology in neurological disorders, visit our publications page.
Meet Sudoscan in Antibes
We invite neurologists, neurophysiologists, clinicians, and researchers attending SF-ENMG 2026 to come and discover Sudoscan throughout the congress.
Join us to:
● Learn more about ESC measurement and small fiber dysfunction
● See the device during live demonstrations
● Discuss real-life clinical applications with our team
SF-ENMG 2026 will be a great opportunity to connect with the French-speaking neurophysiology community and explore innovative approaches in neuropathy assessment.
For full programme details, registration, and practical information, please visit the official SF-ENMG 2026 website.
We look forward to meeting you in Antibes!
